Home - Products - Others - Other Targets - H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2

H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2

CAS No. 149836-35-1

H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2( ——— )

Catalog No. M39929 CAS No. 149836-35-1

H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
25MG Get Quote Get Quote
50MG Get Quote Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2
  • Note
    Research use only, not for human use.
  • Brief Description
    H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2
  • Description
    H-Gly-Pro-Arg-Pro-Pro-Glu-Arg-His-Gln-Ser-NH2
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ———
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    149836-35-1
  • Formula Weight
    ———
  • Molecular Formula
    ———
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • [Met5,Arg6,Phe7] Enk...

    Met-Enkephalin-Arg-Phe is a naturally occurring heptapeptide with analgesic activity.

  • VIR-165

    VIR-165 is a modified form of virus inhibitory peptide (VIRIP), which corresponds to residues 353 to 372 of C-proximal region of human alpha1-antitrypsin, the most abundant circulating serine protease inhibitor. VIRIP inhibits a wide variety of human immunodeficiency virus type 1 (HIV-1) strains.

  • α-Synuclein (61-95) ...

    α-Synuclein (61-95) (human) is the hydrophobic core region of α-synuclein, and induces neuronal cell death. α-Synuclein (61-95) (human) can be used for research of neurodegenerative diseases, including Alzheimer’s disease (AD) and Parkinson’s disease (PD).